Study protocol: HiSNAP trial – a multi-centre, randomised, open label, blinded end-point, safety and efficacy trial of conventional (300mg/kg) versus higher doses of acetylcysteine (450mg/kg and 600mg/kg) in patients with paracetamol overdose in the United Kingdom

Data Availability

Results will be disseminated by peer-reviewed publication, conferences, and linked on isrctn.com. Publication content will follow the Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate) Extension of the CONSORT 2010 Statement. Ownership of data arising from this study resides with the study team at the Sponsor Organisation. The study team will follow the International Committee of Medical Journal Editors guidelines on authorship. Requests for data access should be sent to the corresponding author.